Literature DB >> 20605702

NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia.

Norell M Hadzimichalis, Michelle L Previtera, Michael P Moreau, Bo Li, Gum Hwa Lee, Anna M Dulencin, Paul G Matteson, Steven Buyske, James H Millonig, Linda M Brzustowicz, Bonnie L Firestein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20605702      PMCID： PMC2952053          DOI： 10.1016/j.schres.2010.05.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.

Authors:  Carla Toro; J F W Deakin
Journal:  Schizophr Res       Date:  2005-09-02       Impact factor: 4.939

2.  NOS1AP in schizophrenia.

Authors:  Linda M Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

3.  Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).

Authors:  Ranjna Kapoor; Kelly Sy Lim; Alice Cheng; Therese Garrick; Vimal Kapoor
Journal:  Brain Res       Date:  2006-07-07       Impact factor: 3.252

Review 4.  Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia.

Authors:  W E Bunney; B G Bunney
Journal:  Brain Res Brain Res Rev       Date:  2000-03

5.  CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95.

Authors:  S R Jaffrey; A M Snowman; M J Eliasson; N A Cohen; S H Snyder
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

Review 6.  The cognitive neuroscience of schizophrenia.

Authors:  Deanna M Barch
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

7.  Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.

Authors:  Matthew T Avila; Martin A Weiler; Adrienne C Lahti; Carol A Tamminga; Gunvant K Thaker
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

8.  Identification of a schizophrenia-associated functional noncoding variant in NOS1AP.

Authors:  Naomi S Wratten; Holly Memoli; Yungui Huang; Anna M Dulencin; Paul G Matteson; Michelle A Cornacchia; Marco A Azaro; Jaime Messenger; Jared E Hayter; Anne S Bassett; Steven Buyske; James H Millonig; Veronica J Vieland; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2009-03-02       Impact factor: 18.112

9.  Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder.

Authors:  Bin Xu; Naomi Wratten; Erik I Charych; Steven Buyske; Bonnie L Firestein; Linda M Brzustowicz
Journal:  PLoS Med       Date:  2005-09-13       Impact factor: 11.069
  9 in total
  8 in total

1.  Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons.

Authors:  Damien Carrel; Kristina Hernandez; Munjin Kwon; Christine Mau; Meera P Trivedi; Linda M Brzustowicz; Bonnie L Firestein
Journal:  Biol Psychiatry       Date:  2014-10-30       Impact factor: 13.382

2.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

3.  Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesicles.

Authors:  J Ko; M Hemphill; Z Yang; E Sewell; Y J Na; D K Sandsmark; M Haber; S A Fisher; E A Torre; K C Svane; A Omelchenko; B L Firestein; R Diaz-Arrastia; J Kim; D F Meaney; D Issadore
Journal:  Lab Chip       Date:  2018-10-25       Impact factor: 6.799

4.  d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.

Authors:  Kirsten C Svane; Ericka-Kate Asis; Anton Omelchenko; Ansley J Kunnath; Linda M Brzustowicz; Steven M Silverstein; Bonnie L Firestein
Journal:  Mol Cell Neurosci       Date:  2018-03-27       Impact factor: 4.314

5.  Overexpression of Isoforms of Nitric Oxide Synthase 1 Adaptor Protein, Encoded by a Risk Gene for Schizophrenia, Alters Actin Dynamics and Synaptic Function.

Authors:  Kristina Hernandez; Przemyslaw Swiatkowski; Mihir V Patel; Chen Liang; Natasha R Dudzinski; Linda M Brzustowicz; Bonnie L Firestein
Journal:  Front Cell Neurosci       Date:  2016-02-02       Impact factor: 5.505

6.  Association of nitric oxide synthase 1 adaptor protein gene polymorphisms with schizophrenia in a Chinese Han population.

Authors:  Xueping Yang; Jing Zhou; Zhen Yuan; Ailu Lin; Xin Li; Zhengtu Cong; Ru He; Gang Zhu
Journal:  Indian J Psychiatry       Date:  2022-03-24       Impact factor: 1.759

Review 7.  Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.

Authors:  Andrea de Bartolomeis; Licia Vellucci; Mark C Austin; Giuseppe De Simone; Annarita Barone
Journal:  Biomolecules       Date:  2022-06-29

8.  NOS1AP Interacts with α-Synuclein and Aggregates in Yeast and Mammalian Cells.

Authors:  Anton B Matiiv; Svetlana E Moskalenko; Olga S Sergeeva; Galina A Zhouravleva; Stanislav A Bondarev
Journal:  Int J Mol Sci       Date:  2022-08-14       Impact factor: 6.208
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.